Tarsus Pharmaceuticals TARS
NASDAQ TARS
$78.61 +1.92 (+2.50%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Other financing activities (2022)

Updated

Tarsus Pharmaceuticals (TARS) reported Other financing activities of $31.88 million for FY2024.

Analysis

Tarsus Pharmaceuticals (TARS) Other financing activities (2022) Analysis & Trends

  • According to Business Quant data, Other financing activities came in at $875,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 60,000.00
Mar 31, 2022 815,000.00
API Access

Tarsus Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TARS&period=max&api_key=YOUR_API_KEY